Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Buenos Aires - Delayed Quote • ARS AstraZeneca PLC (AZN.BA) Follow Compare 46,250.00 +275.00 +(0.60%) At close: February 28 at 4:59:36 PM GMT-3 Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for AZN.BA 1D 5D 2.38% 1M 12.67% 3M 24.08% 6M -17.92% YTD 18.74% 1Y 21,461.77% 5Y 21,461.77% All 47,506.79% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent News: AZN.BA View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Here's Why Astrazeneca (AZN) Gained But Lagged the Market Today Pharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & More Drug Stocks Are the New Safe Bet in a Shaky Market AstraZeneca reports positive outcomes from breast cancer combo therapy trial AstraZeneca PLC (AZN): One of the Best Vaccine Stocks to Buy According to Hedge Funds AstraZeneca breast cancer drug shows positive results, shares up Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial AstraZeneca PLC (AZN): A High Growth Mega Cap Stock You Can Buy and Hold for the Next 5 Years Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing AstraZeneca PLC (AZN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts 3 Magnificent Growth Stocks to Buy Right Now Related Tickers GILD.BA Gilead Sciences, Inc. 35,000.00 +2.26% LLY.BA Eli Lilly and Company 19,975.00 +1.14% MRK.BA Merck & Co., Inc. 22,375.00 +1.94% JNJ.BA Johnson & Johnson 13,350.00 +0.95% NVO Novo Nordisk A/S 90.65 +1.60%